AlphAIAlphAI — Financial news for AI agents
Stock TitanMAR 13 min read$IHT

IHT Financials: Income Statement, Balance Sheet & Cash Flow

This article provides a detailed financial analysis of Innsuites Hospitality Trust (IHT), including its income statement, balance sheet, cash flow, and key financial ratios. The company shows weak financial health with a low profitability score, high leverage, and low earnings quality, although it did experience 7.0% revenue growth in fiscal year 2026. Innsuites Hospitality Trust reported a net loss of -$1.4M and a diluted EPS of $-0.16 for FY2026.

Original reporting
Stock Titan
Published Mar 1, 2026, 9:52 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Mar 1, 2026, 10:30 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefFinancial news
Primary signal
$IHT
Bearish
high confidence
Mentioned
$IHT
Relevance
6/10
AlphAI data visualization · based on Stock Titan
Decision brief

The 30-second read

$IHTBearishLow
01

Why it matters

Financial weaknesses suggest caution; bearish sentiment may lead to further declines.

02

Market read

Company-specific financial issues with limited broader market impact.

03

What to watch

Potential for sector-wide recovery or acquisition activity that could mitigate current weaknesses.

Relevance 6/10Timing: short-term (weeks to a few months)

Background

IHT has reported a net loss of $1.4 million for FY2026, with low profitability and high leverage, despite a 7.0% revenue increase.

Company-level read

Ticker impact

$IHTBearishHigh confidence
Context

Financial health and profitability concerns based on recent financial statements.

Expected impact

Potential short-term decline or sideways movement due to financial weakness.

Evidence & confidence

The company's net loss, low earnings quality, high leverage, and bearish sentiment indicate a challenging outlook, likely leading to downward pressure in the near term.

Market effects

Sector

Weak financials may negatively influence the hospitality sector's sentiment and investor confidence.

Regional

Limited regional impact; company-specific issues dominate.

Global

Negligible; company-specific financials unlikely to affect global markets.

Counterpoint

What could challenge this read

If revenue growth accelerates or operational improvements are announced, the stock could recover.

Key entities

  • Company
    Innsuites Hospitality Trust

    A hospitality-focused real estate investment trust.

Read at source← All news

Related articles

OCT 28
$FWRDMed

Forward Air Announces Two-Year Definitive Agreement to Retain Significant Portion of Previously Disclosed Customer Relationship

FORWARD AIR CORP (FWRD) filed an SEC Form 8-K — Other Events. Forward Air Announces Two-Year Definitive Agreement to Retain Significant Portion of Previously Disclosed Customer Relationship 2026 to 2028 Forecasted Annual Revenue from Customer Expected to Exceed 2025 Revenue Driven by Growth in Retained Services DALLAS – October 28, 2026 – F

SEC EDGAR 8-K4 min
OCT 28
$PYPDMedAI 8/10

PolyPid unveils PD01B for diabetic foot infection treatment

PolyPid Ltd. (NASDAQ:PYPD) introduced PD01B, a product candidate for treating moderate to severe diabetic foot infections, using its Kynatrix delivery technology. The company plans to initiate a first-in-human study in the second half of 2027. PolyPid also expects a decision on its lead product D-PLEX₁₀₀ by November 28, 2026, with a potential U.S. launch in early 2027, subject to FDA approval.

investing.com2 min
OCT 28
$KTOSMed

Kratos wins $33.6 million NASA power system contract

Kratos Defense & Security Solutions (KTOS) won a $33.6M contract from NASA to design and build a power system for the Space Reactor-1 Freedom spacecraft, launching in 2028. Kratos will work as a subcontractor to Sierra Lobo under NASA’s SpaceDOC III contract, providing a power conversion system for the mission to Mars. The spacecraft aims to demonstrate nuclear electric propulsion technology. According to the company, the contract is a significant milestone in advancing space nuclear propulsion.

investing.com3 min
OCT 28
$BNTCMedAI 8/10

Benitec Biopharma Announces Positive Interim Phase 1b/2a Results for High Dose BB-301 and Continued Durable Improvements for Low Dose BB-301

Benitec Biopharma Inc. (BNTC) filed an SEC Form 8-K — Regulation FD Disclosure. Exhibit 99.1 Benitec Biopharma Announces Positive Interim Phase 1b/2a Results for High Dose BB-301 and Continued Durable Improvements for Low Dose BB-301 • Both low dose and high dose BB-301 continue to drive robust improvements in swallowing function for dysphagic Patients with

SEC EDGAR 8-K3 min